• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Atara Biotherapeutics

team layoffs workforce
Biotech

Atara lays off more staff despite FDA lifting clinical hold

Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of its workforce.
James Waldron May 13, 2025 10:07am
A series of dice with a bag on them illustrating cost cuts

Atara, reeling from FDA hold on Ebvallo, halves workforce

Mar 4, 2025 8:07am
picture of a paraglider

CRISPR-focused Caribou christens new CMO—Chutes & Ladders

Aug 16, 2024 8:30am
photo of parachutes over a river

Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders

Feb 2, 2024 9:30am
layoffs cut staff reduction workforce

After ph. 2 fail, Atara says goodbye to CMO and 25% of staff

Jan 31, 2024 11:22am
Missed target failed trial trial failure

Atara's stock sinks as MS cell therapy fails in phase 2

Nov 9, 2023 6:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings